Protective Effects of NaHS/miR-133a-3p on Lipopolysaccharide-Induced Cardiomyocytes Injury

Figure 4

QPCR assay and WB were used to detect the expression of related indicators. (a) AMPK and mTOR expressions were determined by qPCR. (b) Western blotting with densitometric analysis of AMPK, mTOR, Beclin-1, P62, and LC3I/II.  ≤ 0.05 compared with the control group, ^# ≤ 0.05 compared with the respective LPS-treated group, and ^& ≤ 0.05 compared with the LPS + NaHS group.

(a)

(b)